Latest research, images & videos from Russian laboratories and universities
Cancer remains one of the greatest medical challenges of our time. In recent years, Russian researchers have announced a series of promising innovations—from cutting-edge vaccines to precision drug-delivery systems. Below is a roundup of the most notable projects, the science behind them, and links to news articles, images and videos you can embed.
Enteromix: Russia’s Experimental mRNA Cancer Vaccine
What it is: Enteromix is an mRNA-based therapeutic vaccine, designed not to prevent cancer, but to train the immune system to find and destroy existing tumors—an approach similar in concept to the mRNA COVID-19 vaccines.
Highlights from research & trials
Initially targeted at colorectal cancer, with future versions planned for glioblastoma and melanoma.
Pre-clinical tests showed tumors shrinking by up to 60–80 %.
Phase-1 human trials began in mid-2025 with 48 volunteers.
Important: The widely-quoted “100 % efficacy” refers to early laboratory or animal data, not to large human trials. Regulatory approval and long-term safety testing are still required.
Modular Nanotransporters — The “Diving Antibodies”
A team led by Alexander Sobolev at the Russian Academy of Sciences has created modular protein nanotransporters, nicknamed “diving antibodies.” These microscopic carriers are designed to enter the nucleus of cancer cells and deliver a toxic payload directly inside, sparing surrounding healthy tissue.
Early laboratory experiments confirm that these nanotransporters can locate tumor cells and penetrate them effectively.
Still in pre-clinical stage—human testing has not yet started.
Another Russian group is engineering a patient’s own T-cells to express tumor-specific T-cell receptors (TCRs)—a therapy somewhat similar to CAR-T but designed for a wider range of solid tumors.
Pre-clinical results show these engineered T-cells can recognize and kill tumor cells.
Researchers have synthesized a novel boron-containing compound that concentrates in tumors and can be used for BNCT—a technique that bombards the tumor with neutrons, killing only the cancerous cells.
Published in the International Journal of Molecular Sciences (2025).
Promising for tumors that are hard to operate on or resistant to conventional therapy.
From personalized mRNA vaccines like Enteromix to nuclear-targeting nanotransporters, Russian researchers are contributing bold ideas to the global fight against cancer. These innovations could become the foundation for future therapies—provided that rigorous clinical testing confirms their promise.
As with any early medical breakthrough, cautious optimism is warranted. The road from laboratory success to widespread patient benefit is long, but these Russian projects show that the global race toward more effective cancer treatments is gaining momentum.